GWM
ZOM

Geneos Wealth Management’s Zomedica Corp. ZOM Stock Holding History

Geneos Wealth Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,000
Closed -$2K – 3206
2021
Q1 		$2K Buy
+2,000
New +$3.27K ﹤0.01% 2973

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
KFS
Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return

Geneos Wealth Management's ZOM Position: Q2 2021 in Review

Geneos Wealth Management sold out of Zomedica Corp. (ZOM) in Q2 2021, closing a stake of 2,000 shares — an estimated $2K sold.

Geneos Wealth Management first reported a position in ZOM in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 106 funds tracked by Wall St. Rank hold ZOM as of Q2 2021.

  • Geneos Wealth Management reported no remaining Zomedica Corp. position as of Q2 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 2,000 Zomedica Corp. shares in Q2 2021, an estimated $2K.
  • Geneos Wealth Management first reported a position in Zomedica Corp. in Q1 2021 and held it in 1 quarter.
  • Geneos Wealth Management's Zomedica Corp. position peaked at $2K in Q1 2021.
  • 106 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.